JP2005504770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504770A5 JP2005504770A5 JP2003521232A JP2003521232A JP2005504770A5 JP 2005504770 A5 JP2005504770 A5 JP 2005504770A5 JP 2003521232 A JP2003521232 A JP 2003521232A JP 2003521232 A JP2003521232 A JP 2003521232A JP 2005504770 A5 JP2005504770 A5 JP 2005504770A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- following formula
- haloalkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 50
- 125000000217 alkyl group Chemical group 0.000 claims 41
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 150000002367 halogens Chemical class 0.000 claims 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 12
- 238000000034 method Methods 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 11
- 229910052802 copper Inorganic materials 0.000 claims 11
- 239000010949 copper Substances 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- 239000012351 deprotecting agent Substances 0.000 claims 6
- 239000002904 solvent Substances 0.000 claims 6
- 239000002738 chelating agent Substances 0.000 claims 5
- 230000008878 coupling Effects 0.000 claims 4
- 238000010168 coupling process Methods 0.000 claims 4
- 238000005859 coupling reaction Methods 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 150000001412 amines Chemical class 0.000 claims 3
- 229940124530 sulfonamide Drugs 0.000 claims 3
- 150000003456 sulfonamides Chemical class 0.000 claims 3
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 2
- -1 -OH Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 2
- 229940125758 compound 15 Drugs 0.000 claims 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000001033 ether group Chemical group 0.000 claims 2
- 150000003459 sulfonic acid esters Chemical class 0.000 claims 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical group N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 229940125773 compound 10 Drugs 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000005561 phenanthryl group Chemical group 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 0 *NCc1ccccc1 Chemical compound *NCc1ccccc1 0.000 description 2
- DIDKWCOCQJWMDJ-UHFFFAOYSA-N Oc(c1ncccc11)c(C(NCc(cc2)ccc2F)=O)nc1N(CCCC1)S1(=O)=O Chemical compound Oc(c1ncccc11)c(C(NCc(cc2)ccc2F)=O)nc1N(CCCC1)S1(=O)=O DIDKWCOCQJWMDJ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31337601P | 2001-08-17 | 2001-08-17 | |
| PCT/US2002/027151 WO2003016309A1 (en) | 2001-08-17 | 2002-08-13 | Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504770A JP2005504770A (ja) | 2005-02-17 |
| JP2005504770A5 true JP2005504770A5 (enExample) | 2006-01-05 |
Family
ID=23215476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003521232A Withdrawn JP2005504770A (ja) | 2001-08-17 | 2002-08-13 | 5−スルホンアミド−8−ヒドロキシ−1,6−ナフチリジン−7−カルボキサミドの製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050014780A1 (enExample) |
| EP (1) | EP1427726A1 (enExample) |
| JP (1) | JP2005504770A (enExample) |
| AR (1) | AR036352A1 (enExample) |
| CA (1) | CA2456155A1 (enExample) |
| WO (1) | WO2003016309A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002030931A2 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| KR101122782B1 (ko) * | 2002-10-04 | 2012-04-12 | 프라나 바이오테크놀로지 리미티드 | 신경 활성 화합물 |
| WO2005028478A1 (en) | 2003-09-19 | 2005-03-31 | Gilead Sciences, Inc. | Aza-quinolinol phosphonate integrase inhibitor compounds |
| WO2006125048A2 (en) * | 2005-05-16 | 2006-11-23 | Gilead Sciences, Inc. | Hiv-integrase inhibitor compounds |
| BRPI0710737A2 (pt) | 2006-04-14 | 2011-05-10 | Prana Biotechnology Ltd | uso de compostos pb-10 33 éteis para o tratamento de degeneraÇço macular relacionada À idade (amd), assim como referidos compostos |
| EP3313420B1 (en) | 2015-06-25 | 2024-03-13 | The Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| DK3429603T3 (da) | 2016-03-15 | 2022-03-14 | Childrens Medical Center | Fremgangsmåder og sammensætninger vedrørende ekspansion af hæmatopoietiske stamceller |
| CA3237199A1 (en) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH214351A (de) * | 1938-08-30 | 1941-04-15 | Cilag Chemisches Ind Lab A G | Verfahren zur Darstellung eines Derivates des 2-Aminopyridins. |
| WO2002030931A2 (en) * | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
-
2002
- 2002-08-13 US US10/486,535 patent/US20050014780A1/en not_active Abandoned
- 2002-08-13 JP JP2003521232A patent/JP2005504770A/ja not_active Withdrawn
- 2002-08-13 CA CA002456155A patent/CA2456155A1/en not_active Abandoned
- 2002-08-13 WO PCT/US2002/027151 patent/WO2003016309A1/en not_active Ceased
- 2002-08-13 EP EP02763531A patent/EP1427726A1/en not_active Withdrawn
- 2002-08-15 AR ARP020103083A patent/AR036352A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4642860B2 (ja) | フルオロアルキルスルホンの光酸発生部が置換された新規の単量体およびその重合体 | |
| JP2005504770A5 (enExample) | ||
| JP2006510719A5 (enExample) | ||
| JP2004501940A5 (enExample) | ||
| JP2004505965A5 (enExample) | ||
| JP2001514282A5 (enExample) | ||
| JP2005507004A5 (enExample) | ||
| JP2004508349A5 (enExample) | ||
| JP2006225632A5 (enExample) | ||
| JP2005526149A5 (enExample) | ||
| JP2009527019A (ja) | 200nm未満リソグラフィー用アダマンタン系分子性ガラスフォトレジスト | |
| JP3254619B2 (ja) | リン系潜伏性触媒の合成法 | |
| RU2004130300A (ru) | Способ синтеза хиральных n-арилпиперазинов | |
| JP2005508930A5 (enExample) | ||
| JP2008506748A5 (enExample) | ||
| ATE419230T1 (de) | Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin | |
| JP2000212158A (ja) | スルホニウム塩及びその製造方法 | |
| JP2003261506A5 (enExample) | ||
| JP2011001298A (ja) | アリール基を有するスルホニウム塩の製造法 | |
| JP3769192B2 (ja) | 2−(n−フェニルアミノ)安息香酸の製造方法 | |
| JP2000110076A5 (enExample) | ||
| EP1604968A1 (en) | Acetylene alcohols having a fluoroalkyl group and methods for preparing the same | |
| JP2001166485A5 (enExample) | ||
| JP2002241331A5 (enExample) | ||
| JPH10251374A5 (enExample) |